Acta Scientific Cancer Biology (ASCB)

Review Article Volume 4 Issue 8

Cancer: New Treatments, New Lines of Research

Adrian P Hunis*

Department of Clinical Oncology, Universidad de Buenos Aires (UBA), Argentina

*Corresponding Author: Adrian P Hunis, Department of Clinical Oncology, Universidad de Buenos Aires (UBA), Argentina.

Received: July 09, 2020; Published: July 28, 2020

Reprints View PDF Related Articles

×

Abstract

 Although it may be contradictory, the following sentence is very true: the news about cancer every day is better: new treatments, new lines of research, revolutionary drugs approved by health agencies and fewer premature deaths thanks to the chronicity of the disease are some of the news that every week brings medicine to the cure of this terrible disease.

Keywords: Cancer; Chronicity of the Disease; Revolutionary Drugs

×

Citation

Citation: Adrian P Hunis. “Cancer: New Treatments, New Lines of Research”. Acta Scientific Cancer Biology 4.8 (2020): 14-18.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.